| CEO: | Phil L'Huillier |
| CFO: | Sath Nirmalananthan |
| Chief Scientific Officer: | Lindy Durrant |
| Deputy Chairman: | Susan Clement Davies |
| Non-Executive Chairman: | Jean-Michel Cosséry |
| Non-Executive Dir: | Martin Diggle , Ursula Ney, Florian Reinaud |
| Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
| Website: | http://www.scancell.co.uk/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BX8KRW34 |
| Currency | UK Pounds |
| Share Price | 89.00p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 265.00 |
| 52 Week Low | 88.00 |
| Volume | 106,170 |
| Shares Issued | 121.22m |
| Market Cap | £107.89m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:25 | 700 @ 88.89p |
| 15:39 | 354 @ 88.10p |
| 14:58 | 1,683 @ 88.94p |
| 13:45 | 24,722 @ 88.96p |
| 14:43 | 130 @ 88.95p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research